SecBot SecBot
Insider Cluster (3 insiders) ·Filed Aug 6, 2026

CSTL

CASTLE BIOSCIENCES INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 3 insiders, $0.2M total
Actionable Insight • Neutral

No bearish signal from this cluster. The small dollar amount, derivative-exercise pattern, and C-suite-only makeup indicate option-vesting liquidity sales. Monitor for any subsequent change in company guidance or clinical data releases, but on its own this filing is not actionable.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
CSTL ▲ +2.75% at T+20d
NEUTRAL call +2.75% · α vs SPY +3.14% · entry $32.03 → $32.91
Next anchor: T+60d in 2d
Latest observation: T+55 -25.10% FF3 residual α
Entry = T+0 close
Aug 6, 2026
via day close
T+1d
+1.00%
call +1.00% · α +1.03%
$32.35
settled 3mo ago
T+5d
-7.52%
call -7.52% · α -7.92%
$29.62
settled 3mo ago
T+20d
+2.75%
call +2.75% · α +3.14%
$32.91
settled 8w ago
T+60d
Pending
in 2d

Price Chart

Loading chart...

Executive Summary

Three C-suite insiders at Castle Biosciences, including the CEO and COO, sold shares worth a combined ~$240K over a two-day window. The sales represent a very small fraction of the ~$931M market cap (<<0.1%), making them routine in size. The CEO also had derivative exercises at nominal cost during the same period, indicating that the sales are tied to option vesting rather than a directional negative view.

Key Financial Metrics

Direction
selling
Total Value
$240.0K
Insiders
3

Key Facts

  • Total insider sales of ~$240K (open-market) over two days
  • CEO Derek Maetzold sold ~$104K; COO Kristen Oelschlager sold ~$87K; CCO Tobin Juvenal sold ~$49K
  • CEO exercised derivatives (2,546 and 10,664 shares at $2.39) concurrently with sales—strongly suggests 10b5-1/vesting-driven transaction
  • Sales represent <0.03% of $931M market cap—trivial relative to company size

Financial Impact

~$240K in total insider open-market sales, ~0.03% of market cap—immaterial to company valuation

insider holdings

Risk Factors

  • Management selling into strength could signal lack of conviction if sales accelerate or increase in size materially

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CSTL-1786082650448
31 reports for CSTL
Performance horizon
60% Hit rate @ T+1 6 of 10 directional calls Went positive at some point 9 of 10 best @ T+60▲ +27.32%Mar 5, 2026
Filters
Rows
Reports for CSTL — sortable, filterable
TypeNow
Oct 21, 2026
6d ago
Insider Cluster
NEUTRAL ★ 3/10
$33.19 $33.08▼ −0.33%▲ +0.19%$34.51 (+3.98%)
Oct 5, 2026
22d ago
144
NEUTRAL ★ 4/10
$33.36 $33.00▼ −1.08%▼ −0.84%$34.51 (+3.45%)
Oct 5, 2026
22d ago
Insider Cluster
NEUTRAL ★ 2/10
$33.36 $33.00▼ −1.08%▼ −0.84%$34.51 (+3.45%)
Sep 23, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$35.19 $35.81▼ −1.76%▼ −1.22%$34.51 (+1.93%)
Sep 16, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$36.78 $35.34▼ −3.92%▼ −4.04%$34.51 (−6.17%)
Sep 11, 2026
6w ago
144
NEUTRAL ★ 4/10
$33.44 $35.50▲ +6.16%▲ +6.62%$34.51 (+3.20%)
Sep 3, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$32.91 $32.76▲ +0.46%▼ −0.09%$34.51 (−4.86%)
Sep 2, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$32.65 $32.91▲ +0.80%▲ +1.18%$34.51 (+5.70%)
Sep 1, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$33.42 $32.65▼ −2.30%▼ −3.35%$34.51 (+3.26%)
Aug 27, 2026
8w ago
Insider Cluster
NEUTRAL ★ 4/10
$33.50 $33.03▼ −1.40%▼ −1.10%$34.51 (+3.01%)
Showing 10 of 31

US Market Status

Market Closed — Opens in 8h 25m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 7, 2026